← Open Payments lookup

BRIDGETT FISK: Open Payments

NPI 1548889116 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,766 in 202 payments from 19 companies in 2025. Trend: 2023 $2,660 · 2024 $3,537 · 2025 $3,766

Food & beverage: $3,573Education: $193
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.30$730
Teva Pharmaceuticals USA, Inc.28$660
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$427
Otsuka America Pharmaceutical, Inc.24$307
ABBVIE INC.21$288
Axsome Therapeutics, Inc.14$246
Lundbeck LLC10$216
Vanda Pharmaceuticals Inc.11$175
E.R. Squibb & Sons, L.L.C.14$164
Janssen Pharmaceuticals, Inc5$153

Products named: INGREZZA, CAPLYTA, REXULTI, VRAYLAR, AUSTEDO XR, Auvelity, ABILIFY ASIMTUFII, UZEDY.

Industry payments across TX — which companies pay providers there.